Vetsys Pharmaceutical
Vetsys Pharmaceutical
Advanced lipid-based delivery vectors, active drug suspensions, and clinical-grade therapeutic oils engineered for optimized bioavailability.
Within modern veterinary pharmacology, lipid-based therapeutic delivery vectors have revolutionized how active pharmaceutical ingredients (APIs) are administered and absorbed. Hydrophobic molecules, fragile proteins, and highly concentrated antibiotics require specialized vehicles to preserve molecular structural integrity, control release kinetics, and optimize bioavailability.
Traditional aqueous formulations frequently fail when delivering critical compounds such as Cefquinome Sulfate or Ampicillin. Oil-based carriers shield these compounds from hydrolytic degradation, offering sustained-release dynamics that drastically reduce dose frequency. This optimization improves clinical outcomes and minimizes animal handling stress, especially in intensive livestock farming and dairy production.
Furthermore, the physical dynamics of medicinal oils—such as viscosity profiles, sedimentation rates, and syringeability—directly influence treatment efficiency. As global regulatory bodies demand stricter control over residue levels and antibiotic resistance, precision engineering of lipid vectors has transitioned from a specialized process to a fundamental requirement in veterinary pharmaceutical design.
A global leader in veterinary drug synthesis, state-of-the-art lipid suspension processing, and international GMP compliance.
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) is a leading manufacturer in the animal pharmaceutical industry with a registered capital of 30 million RMB. Our production infrastructure features specialized workshops designed to manufacture a diverse range of veterinary therapeutics. Our product line includes powder premixes, sterile liquid injections, powder injections, oral solutions, tablets, granules, herbal drug extracts, and targeted disinfectants.
At Vetsys, operational integrity is governed by rigorous adherence to international Good Manufacturing Practices (GMP). Every batch is manufactured under controlled ambient conditions to guarantee chemical stability and sterility. By leveraging advanced automation and strict quality assurance, Vetsys grew to become one of the top animal pharmaceutical producers in China, achieving annual sales exceeding USD 20 million in the domestic market by 2015.
Vetsys sets itself apart through its focus on continuous technological innovation. We have established an independent research institute equipped with five specialized laboratories and staffed by world-class scientists. This R&D infrastructure allows us to rapidly adapt to market shifts and synthesize cutting-edge therapeutic solutions for animal health.
Our long-term corporate vision is centered on environmental sustainability and global commercial integration. We continuously invest in green synthesis technologies and ecological conservation strategies to reduce the carbon footprint of our chemical manufacturing facilities. Currently, Vetsys is expanding its global distribution networks, bringing high-efficacy veterinary health products to agricultural markets worldwide.
Developing next-generation lipid carrier systems to maximize therapeutic efficacy while minimizing residues.
Developing self-emulsifying drug delivery systems (SEDDS) that improve the biological absorption of hydrophobic antibiotics, ensuring rapid action at lower doses.
Using molecular rheology modifiers to design intramammary infusions that remain stable in varying climates, ensuring consistent syringeability in cold environments and prolonged tissue adhesion at body temperature.
Synthesizing fully biodegradable vegetable oil structures that leave no toxic chemical trace in animal tissues, aligning with strict EU and FDA food safety regulations.
In commercial dairy farming, bovine mastitis remains a primary challenge, causing significant economic loss and reducing milk quality worldwide. Controlling this condition requires fast-acting, highly localized treatments. Vetsys addresses this challenge with our range of intramammary infusions, including Compound Amoxicillin Intramammary Infusion (with Sulbactam Sodium and Prednisolone) and Cefquinome Sulfate Intramammary Infusion.
Our micro-suspension formulations are designed to distribute active ingredients evenly throughout the mammary gland. By using high-purity lipid excipients, our infusions adhere to mucosal tissues, preventing wash-out during normal lactation cycles. Adding anti-inflammatory components like Prednisolone helps reduce tissue swelling, allowing the companion antibiotics to penetrate deep into infected micro-capillaries.
For farm-wide disease control, Vetsys provides broad-spectrum antiparasitics like Amitraz Solution 12.5% and Avermectin Pour-On Solution. These formulations eliminate external vectors that spread systemic pathogens, helping agricultural businesses maintain high biosecurity standards.
Take a closer look at our advanced manufacturing lines. We integrate automated molding, precise synthesis, and sterile packaging under strict quality control standards.
By integrating automated hardware manufacturing processes (such as precision blow molding, extrusion molding, and advanced injection molding) directly with our sterile pharmaceutical formulation suites, Vetsys achieves a highly vertical manufacturing workflow. This configuration allows us to manufacture both the veterinary applicator packaging (e.g., custom intramammary infusion syringes) and the active therapeutic suspensions on the same site. This system minimizes contamination risks, guarantees strict airtightness, and simplifies global procurement logistics for our customers.
Meeting international quality standards to support registration and commercial distribution in global markets.
Our regulatory affairs department provides comprehensive document support, including Certificate of Pharmaceutical Product (CPP), Chemistry, Manufacturing, and Controls (CMC) dossiers, and stability testing reports. We assist our international partners through local registration processes with national ministries of agriculture and health, ensuring compliant market entry.
Our five specialized laboratories monitor product quality from raw material identification to final shelf-life studies. Using advanced analytical tools such as High-Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC), we verify active ingredient purity, monitor emulsion stability, and ensure zero cross-contamination in every batch.
Explore our complete catalog of veterinary solutions, natural plant-based extracts, and targeted clinical-grade preparations.
Ensuring quality, security, and logisitcal efficiency for global commercial partners.
For B2B procurement managers, sourcing veterinary pharmaceuticals involves balancing quality standards, price efficiency, and delivery reliability. An unstable supply chain can lead to stock shortages, import issues, or out-of-specification batches, which directly impact commercial distribution.
Vetsys mitigates these procurement risks by implementing strict quality control systems. Our integrated production facilities manufacture both the plastic container packaging and the active drug formulations on-site, reducing reliance on third-party suppliers and lowering production costs. We source our raw materials from verified, long-term partners, verifying the chemical purity of each lot before it enters the manufacturing process.
Our logistical operations are designed for international shipping, utilizing moisture-resistant packaging and temperature-controlled shipping methods to maintain product stability during long-distance transport. Whether you are sourcing bulk powders, sterile suspensions, or customized packaging, Vetsys provides reliable delivery and regulatory support to ensure consistent product supply.
Providing direct answers to technical questions about formulation stability, delivery systems, and regulatory standards.